Morimoto H - Search Results

1

Studies on neurokinin antagonists. 1. The design of novel tripeptides possessing the glutaminyl-D-tryptophylphenylalanine sequence as substance P antagonists.

Hagiwara D, Miyake H, Morimoto H, Murai M, Fujii T, Matsuo M. Hagiwara D, et al. Among authors: morimoto h. J Med Chem. 1992 May 29;35(11):2015-25. doi: 10.1021/jm00089a011. J Med Chem. 1992. PMID: 1375965

2

Effects of FR 113680 and FK 224, novel tachykinin receptor antagonists, on cigarette smoke-induced rat tracheal plasma extravasation.

Morimoto H, Yamashita M, Matsuda A, Miyake H, Fujii T. Morimoto H, et al. Eur J Pharmacol. 1992 Nov 24;224(1):1-5. doi: 10.1016/0014-2999(92)94810-i. Eur J Pharmacol. 1992. PMID: 1280594

3

Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888.

Fujii T, Murai M, Morimoto H, Maeda Y, Yamaoka M, Hagiwara D, Miyake H, Ikari N, Matsuo M. Fujii T, et al. Among authors: morimoto h. Br J Pharmacol. 1992 Nov;107(3):785-9. doi: 10.1111/j.1476-5381.1992.tb14524.x. Br J Pharmacol. 1992. PMID: 1282073 Free PMC article.

4

FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.

Morimoto H, Murai M, Maeda Y, Yamaoka M, Nishikawa M, Kiyotoh S, Fujii T. Morimoto H, et al. J Pharmacol Exp Ther. 1992 Jul;262(1):398-402. J Pharmacol Exp Ther. 1992. PMID: 1378096

5

FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.

Morimoto H, Murai M, Maeda Y, Hagiwara D, Miyake H, Matsuo M, Fujii T. Morimoto H, et al. Br J Pharmacol. 1992 May;106(1):123-6. doi: 10.1111/j.1476-5381.1992.tb14303.x. Br J Pharmacol. 1992. PMID: 1380378 Free PMC article.

6

Studies on neurokinin antagonists. 2. Design and structure-activity relationships of novel tripeptide substance P antagonists, N alpha-[N alpha-(N alpha-acetyl-L-threonyl)-N1-formyl-D-tryptophyl]-N- methyl-N-(phenylmethyl)-L-phenylalaninamide and its related compounds.

Hagiwara D, Miyake H, Morimoto H, Murai M, Fujii T, Matsuo M. Hagiwara D, et al. Among authors: morimoto h. J Med Chem. 1992 Aug 21;35(17):3184-91. doi: 10.1021/jm00095a013. J Med Chem. 1992. PMID: 1380560

7

Effects of the tripeptide substance P antagonist, FR113680, on airway constriction and airway edema induced by neurokinins in guinea-pigs.

Murai M, Morimoto H, Maeda Y, Fujii T. Murai M, et al. Among authors: morimoto h. Eur J Pharmacol. 1992 Jun 24;217(1):23-9. doi: 10.1016/0014-2999(92)90506-y. Eur J Pharmacol. 1992. PMID: 1383004

8

Studies on neurokinin antagonists. 3. Design and structure-activity relationships of new branched tripeptides N alpha-(substituted L-aspartyl, L-ornithyl, or L-lysyl)-N-methyl-N-(phenylmethyl)-L-phenylalaninamides as substance P antagonists.

Hagiwara D, Miyake H, Murano K, Morimoto H, Murai M, Fujii T, Nakanishi I, Matsuo M. Hagiwara D, et al. Among authors: morimoto h. J Med Chem. 1993 Aug 6;36(16):2266-78. doi: 10.1021/jm00068a003. J Med Chem. 1993. PMID: 7689652

9

Design of a novel dipeptide substance P antagonist FK888.

Hagiwara D, Miyake H, Igari N, Murano K, Morimoto H, Murai M, Fujii T, Matsuo M. Hagiwara D, et al. Among authors: morimoto h. Regul Pept. 1993 Jul 2;46(1-2):332-4. doi: 10.1016/0167-0115(93)90076-k. Regul Pept. 1993. PMID: 7692528 No abstract available.

10

Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.

Murai M, Morimoto H, Maeda Y, Kiyotoh S, Nishikawa M, Fujii T. Murai M, et al. Among authors: morimoto h. J Pharmacol Exp Ther. 1992 Jul;262(1):403-8. J Pharmacol Exp Ther. 1992. PMID: 1378097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

844 results

Search Page